These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8717381)
1. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants. Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of cellular changes in mice after intradermal inoculation with a liposome-iscom adjuvanted vaccine. San Gil F; Turner B; Mullbacher A; Walker MJ; Djordjevic SP; Eamens GJ; Chin JC Scand J Immunol; 1998 Mar; 47(3):243-53. PubMed ID: 9519863 [TBL] [Abstract][Full Text] [Related]
3. Novel vaccination strategies for the control of mucosal infection. Husband AJ Vaccine; 1993; 11(2):107-12. PubMed ID: 8438609 [TBL] [Abstract][Full Text] [Related]
4. Oral vaccine models: multiple delivery systems employing tetanus toxoid. Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173 [TBL] [Abstract][Full Text] [Related]
5. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Kim SH; Jang YS Exp Mol Med; 2014 Mar; 46(3):e85. PubMed ID: 24626171 [TBL] [Abstract][Full Text] [Related]
6. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Mestecky J; Michalek SM; Moldoveanu Z; Russell MW Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757 [TBL] [Abstract][Full Text] [Related]
7. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877 [TBL] [Abstract][Full Text] [Related]
9. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine. Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635 [TBL] [Abstract][Full Text] [Related]
10. Impaired mucosal immune responses in interleukin 4-targeted mice. Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021 [TBL] [Abstract][Full Text] [Related]
11. Immune responses of a liposome/ISCOM vaccine adjuvant against streptococcal fibronectin binding protein 1 (Sfb1) in mice. McArthur J; Schulze K; Chin J; Currie BJ; Sriprakash KS; Talay SR; Chhatwal GS; Guzmán CA; Walker MJ Indian J Med Res; 2004 May; 119 Suppl():115-20. PubMed ID: 15232175 [TBL] [Abstract][Full Text] [Related]
12. Functional characteristics of Peyer's patch lymphoid cells. II. Lipopolysaccharide is thymus dependent. Kagnoff MF; Billings P; Cohn M J Exp Med; 1974 Feb; 139(2):407-13. PubMed ID: 4589992 [TBL] [Abstract][Full Text] [Related]
13. Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens. Kofler N; Ruedl C; Rieser C; Wick G; Wolf H Int Arch Allergy Immunol; 1997 Aug; 113(4):424-31. PubMed ID: 9250588 [TBL] [Abstract][Full Text] [Related]
14. New generation of mucosal adjuvants for the induction of protective immunity. Yuki Y; Kiyono H Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340 [TBL] [Abstract][Full Text] [Related]
15. Lambda display phage as a mucosal vaccine delivery vehicle for peptide antigens. González-Cano P; Gamage LNA; Marciniuk K; Hayes C; Napper S; Hayes S; Griebel PJ Vaccine; 2017 Dec; 35(52):7256-7263. PubMed ID: 29153779 [TBL] [Abstract][Full Text] [Related]
16. Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration. Shroff KE; Marcucci-Borges LA; de Bruin SJ; Winter LA; Tiberio L; Pachuk C; Snyder LA; Satishchandran C; Ciccarelli RB; Higgins TJ Vaccine; 1999 Sep; 18(3-4):222-30. PubMed ID: 10506646 [TBL] [Abstract][Full Text] [Related]
17. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant. Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383 [TBL] [Abstract][Full Text] [Related]